Literature DB >> 4277400

Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasmin.

C R Prentice, W Edgar, G P McNicol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4277400     DOI： 10.1111/j.1365-2141.1974.tb06776.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Antimetastatic effect of defibrinogenation with batroxobin depends on the natural killer activity of host in mice.

Authors:  M Shibuya; H Niitani; A Aoyama; S Kawachi; N Nukariya; M Baba; K Iizuka; S Sakai; M Ohtsuka
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 2.  Disseminated intravascular coagulation: a review.

Authors:  P J Hamilton; A L Stalker; A S Douglas
Journal:  J Clin Pathol       Date:  1978-07       Impact factor: 3.411

3.  Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.

Authors:  P J Gaffney
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.